Studies have shown that flavonoid compounds can treat PF [13], and suppressing TGF-β1 induces myofibroblast activation and reduces the production of ECM, thereby alleviating PF [14,15]. The gene discussed is TGFB1; the disease is pemphigus foliaceus.